Please login first

Biomedicines Webinar | Emerging Trends in Pathophysiology and Therapy of COVID-19

Part of the MDPI Biomedicines Webinars series
4 Jun 2024, 17:00 (CEST)

Registration Deadline
4th June 2024

COVID-19, SARS-CoV-2, Viral Infections
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Contact Us

Welcome from the Chair

14th Biomedicines Webinar

Emerging Trends in Pathophysiology and Therapy of COVID-19

I am pleased to serve as the Chairman of this webinar on Emerging Trends in Pathophysiology and Therapy of COVID-19.

Although the worst of the SARS CoV-2 pandemic is behind us, many questions and issues persist. Systemic manifestations due to COVID-19 infections and long COVID continue to emerge in multiple countries. There are a few new USA FDA-approved vaccines available in addition to the Moderna, Pfizer, and Johnson and Johnson ones, but vaccine effectiveness and immunologic memory appear to be limited in most patients.

Therapies are available and should be incorporated into treatment plans for COVID-19 patients. Although the focus of these therapies is on hospitalized COVID-19 patients, orally delivered medications are now administered by health care providers.

This webinar will present discussions on these issues, as well as emerging trends, to understand COVID-19 infections and transmissibility more fully.

Date: 4 June 2024 at 5:00 CEST | 11:00 a.m. EDT | 11:00 p.m. CST Asia
Webinar ID:
828 4947 7200
Webinar Secretariat:
journal.webinar@mdpi.com

Event Chair

University of Maryland,
University of Washington,
Nova Southeastern University,
Temple University

Introduction
Talk
Periodontal Disease Implications for COVID-19 Infections
Bio
Prof. Dr. Jon Suzuki holds Clinical Professorships at the University of Maryland, the University of Washington, and Nova Southeastern University. He is Professor Emeritus of Microbiology and Immunology (School of Medicine) and Professor Emeritus of Periodontology and Oral Implantology (School of Dentistry) at Temple University, Philadelphia, PA., USA. He is also a Special Government Agent for the Food and Drug Administration (FDA) Dental Products Advisory Panel. Dr. Suzuki received his D.D.S. from Loyola University of Chicago and his Ph.D. in Microbiology from the Illinois Institute of Technology. He completed an N.I.H. Fellowship in Immunology at the University of Washington, and a Clinical Certificate in Periodontics at the University of Maryland.
Email
jsuzuki@temple.edu

Keynote Speakers

University of Maryland, USA,
University of Washington, USA,
Nova Southeastern University, USA,
Temple University, USA

Introduction
Talk
Periodontal Disease Implications for COVID-19 Infections
Bio
Prof. Dr. Jon Suzuki holds Clinical Professorships at the University of Maryland, the University of Washington, and Nova Southeastern University. He is Professor Emeritus of Microbiology and Immunology (School of Medicine) and Professor Emeritus of Periodontology and Oral Implantology (School of Dentistry) at Temple University, Philadelphia, PA., USA. He is also a Special Government Agent for the Food and Drug Administration (FDA) Dental Products Advisory Panel. Dr. Suzuki received his D.D.S. from Loyola University of Chicago and his Ph.D. in Microbiology from the Illinois Institute of Technology. He completed an N.I.H. Fellowship in Immunology at the University of Washington, and a Clinical Certificate in Periodontics at the University of Maryland.
Email
jsuzuki@temple.edu

Department of Pharmacy, University of Salerno, Italy

Introduction
Talk
Emerging Trends in Post-COVID-19 therapy
Bio
Dr. Sorrentino's research focuses on the understanding and analysis of inflammation pathways and immune cells involved in acute and chronic lung pathologies.
Email
rsorrentino@unisa.it

Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy

Introduction
Talk
COVID-19: From Pathophysiology to Therapy: The Leading Role of Autopsy 4 Years After The Lockdown of Science
Bio
Active in the fields of forensic pathology and toxicology, bioethics and clinical risk management, and medical liability. Research interests include forensic autopsy technique, forensic pathology, forensic toxicology, cardiopathology, sudden death, and clinical risk management. Expert witness for the Italian Courts. Manager of the Registry of Sudden Cardiac Death in Friuli-Venezia Giulia, Italy.
Email
sderrico@units.it

Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy

Introduction
Talk
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19
Bio
Dr. D'Alessandro started her research in translational medicine for lung diseases with the project "Interaction between solid lipid nanoparticles and respiratory epithelial cells: in vitro study of uptake and biocompatibility". Since then, D'Alessandro has researched novel biomarkers of diffuse lung diseases, asthma, COVID-19, and lung transplantation. Her research focuses on the immune system in different biological matrices - including bronchoalveolar lavage of fibrotic interstitial lung disease patients and the validation of novel biomarkers such as the Krebs von den Lungen-6 and extracellular vesicles.
Email
dalessandro.miriana@gmail.com

Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy

Introduction
Talk
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19
Bio
Dr. Gangi is a PhD candidate in the Respiratory Diseases Unit at the University of Siena. Her project focuses on the analysis of prognostic and diagnostic biomarkers in fibrotic interstitial lung diseases, COVID-19, and lung transplants. Dr. Gangi has developed a good knowledge base on cell culture, flow cytometry analysis, and chemiluminescent methods. She worked on the development of a novel fibroblast cell line isolated by bronchoalveolar lavage of IPF patients. She has authored/coauthored 17 research documents and given lectures at national/international congresses.
Email
sara.gangi@student.unisi.it

Registration

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic or institutional email addresses will be prioritized.

Unable to attend? Feel free to still register, we’ll let you know when the recording is available to watch.

Program

Speaker/Presentation Time in CEST

Prof. Dr. Jon Suzuki
Chair Introduction

Periodontal Disease Implications for COVID
5:005:30 pm
Dr. Rosalinda Sorrentino
Emerging Trends in Post-COVID-19 Therapy
5:305:50 pm
Prof. Dr. Stefano D'Errico
COVID-19: From Pathophysiology to Therapy: The Leading Role of Autopsy 4 Years After The «Lockdown of Science»
5:50–6:10 pm
Dr. Mariana D’Alessandro
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19 (Part 1)
6:106:20 pm
Dr. Sara Gangi
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19 (Part 2)
6:206:30 pm
Q&A 6:306:45 pm
Prof. Dr. Jon Suzuki
Closing of Webinar
6:456:50 pm

Relevant Special Issue

Emerging Trends in Pathophysiology and Therapy of COVID-19

Guest Editors: Dr. Jon B. Suzuki, Dr. Miriam Ting
Deadline for manuscript submissions: 31 October 2024

Sponsors and Partners

Organizers

Top